Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study

Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study

Abstract Sputnik-V (Gam-COVID-Vac) is a heterologous, recombinant adenoviral (rAdv) vector-based, COVID-19 vaccine now used in > 70 countries. Yet there is a shortage of data on this vaccine's performance in diverse populations. Here, we performed a prospective cohort study to assess the rea...

Full description

Bibliographic Details
Main Authors:	Sergey Yegorov, Irina Kadyrova, Baurzhan Negmetzhanov, Yevgeniya Kolesnikova, Svetlana Kolesnichenko, Ilya Korshukov, Yeldar Baiken, Bakhyt Matkarimov, Matthew S. Miller, Gonzalo H. Hortelano, Dmitriy Babenko
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-08-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-17514-3

Similar Items

SG-APSIC1054: Sputnik-V postvaccination immunologic responses in nasal mucosa: A prospective cohort study in Kazakhstan
by: Irina Kadyrova, et al.
Published: (2023-02-01)

High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination
by: Irina Kadyrova, et al.
Published: (2022-01-01)

High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination.
by: Irina Kadyrova, et al.
Published: (2022-01-01)

SG-APSIC1053: Detection of SARS-COV-2 in nasopharyngeal swags with MALDI-TOF MS and machine learning
by: Irina Kadyrova, et al.
Published: (2023-02-01)

Cell Encapsulation Within Alginate Microcapsules: Immunological Challenges and Outlook
by: Assem Ashimova, et al.
Published: (2019-12-01)

Role of Base Excision Repair Pathway in the Processing of Complex DNA Damage Generated by Oxidative Stress and Anticancer Drugs
by: Yeldar Baiken, et al.
Published: (2021-01-01)

Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study
by: Assem Ashimova, et al.
Published: (2022-09-01)

The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation.
by: Anar Turmukhambetova, et al.
Published: (2023-01-01)

Methods for predicting vaccine immunogenicity and reactogenicity
by: Patrícia Gonzalez-Dias, et al.
Published: (2020-02-01)

Immunogenicity evaluation of Gam-COVID-Vac (Sputnik V)
by: I. A. Kirillov, et al.
Published: (2022-12-01)

Immunogenicity and Reactogenicity in Q Fever Vaccine Development
by: Alycia P. Fratzke, et al.
Published: (2022-05-01)

Elevated Levels of Plasma Collagen Triple Helix Repeat Containing 1 (CTHRC1) Are Strongly Associated with eGFR and Albuminuria in Chronic Kidney Disease
by: Yeldar Baiken, et al.
Published: (2023-03-01)

COMPARISON OF REACTOGENICITY AND IMMUNOGENICITY OF LIVE VACCINES AGAINST INFECTIOUS LARYNGOTRACHEITIS
by: S. A. Pokhvalny, et al.
Published: (2018-05-01)

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
by: Jisun Lee, et al.
Published: (2023-07-01)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010-01-01)

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
by: Chenchit Chayachinda, et al.
Published: (2023-08-01)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010-07-01)

Assessment of Reactogenicity and Immunogenicity of the Quadrivalent Live Attenuated Influenza Vaccine
by: D. A. Lioznov, et al.
Published: (2018-06-01)

Can reactogenicity predict immunogenicity after COVID-19 vaccination?
by: Young Hoon Hwang, et al.
Published: (2021-11-01)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
by: Waleed H. Mahallawi, et al.
Published: (2021-12-01)

Psoriasis Is Associated With Elevated Gut IL-1α and Intestinal Microbiome Alterations
by: Sergey Yegorov, et al.
Published: (2020-10-01)

Sputnik + 50
by: Fabrizio Bernardini
Published: (2007-03-01)

Sputnik + 50
by: Fabrizio Bernardini
Published: (2007-03-01)

Detection of Hepatitis E Antibodies in Kazakhstan: A Pilot Study
by: Francesca Cainelli, et al.
Published: (2018-02-01)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
by: Thuy Trang Nguyen, et al.
Published: (2022-03-01)

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations
by: Suvimol Niyomnaitham, et al.
Published: (2023-01-01)

Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system
by: Mostafa Enayatrad, et al.
Published: (2023-03-01)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
by: Diggle, L, et al.
Published: (2006)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial.
by: Diggle, L, et al.
Published: (2006)

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
by: Stilla Bauernfeind, et al.
Published: (2021-09-01)

Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
by: Yufei Wu, et al.
Published: (2023-07-01)

Sputnik, scientists and Eisenhower /
by: 401761 Killian, James Rhyne
Published: (1977)

Data on immunogenicity and reactogenicity to COVID-19 vaccination among patients receiving maintenance dialysis
by: Hristos Karakizlis, et al.
Published: (2022-06-01)

Sputnik and Some of Its Offshootniks
by: Arthur Minton
Published: (1958-06-01)

The EU’s “Ban” of RT and Sputnik
by: Björnstjern Baade

THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS
by: I. V. Feldblum, et al.
Published: (2014-06-01)

Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran
by: Farhang Babamahmoodi, et al.
Published: (2021-11-01)

A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants
by: Vibhu Kanchan, et al.
Published: (2020-03-01)

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
by: Amir I. Tukhvatulin, et al.
Published: (2022-12-01)

Chargaff’s second parity rule lies at the origin of additive genetic interactions in quantitative traits to make omnigenic selection possible
by: Bakhyt T. Matkarimov, et al.
Published: (2023-12-01)